Karen Linehan
Director/Board Member at VEON LTD.
Net worth: 135 456 $ as of 2024-04-29
Profile
Ms. Karen Linehan is an Independent Non-Executive Director at CNH Industrial NV, an Independent Non-Executive Director at VEON Ltd., an Independent Director at Aelis Farma SA and a Member-Visitors Board at Georgetown University Law Center.
She is on the Board of Directors at CNH Industrial NV, VEON Ltd., Aelis Farma SA, Hoechst GmbH, Sanofi-Aventis Deutschland GmbH and Global Antibiotic Research & Development Partnership.
Ms. Linehan was previously employed as an Executive VP-Legal Affairs & General Counsel by Sanofi, an Associate by Townley & Updike, and a Member-Supervisory Board by EUROAPI SA. She received her undergraduate degree from Georgetown University and a graduate degree from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CNH INDUSTRIAL NV
0.00% | 2024-02-28 | 11,903 ( 0.00% ) | 135 456 $ | 2024-04-29 |
Karen Linehan active positions
| Companies | Position | Start |
|---|---|---|
| VEON LTD. | Director/Board Member | 2022-01-03 |
| AELIS FARMA | Director/Board Member | 2021-12-31 |
| CNH INDUSTRIAL N.V. | Director/Board Member | 2022-03-10 |
Hoechst GmbH
 Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Director/Board Member | - |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Director/Board Member | - |
Global Antibiotic Research & Development Partnership
 Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Director/Board Member | - |
| Georgetown University Law Center | Corporate Officer/Principal | - |
Former positions of Karen Linehan
| Companies | Position | End |
|---|---|---|
| SANOFI | General Counsel | 2021-12-30 |
| EUROAPI | Director/Board Member | - |
Training of Karen Linehan
| Georgetown University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| SANOFI | Health Technology |
| VEON LTD. | Communications |
| AELIS FARMA | Health Technology |
| CNH INDUSTRIAL N.V. | Producer Manufacturing |
| EUROAPI | Health Technology |
| Private companies | 3 |
|---|---|
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Health Technology |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Health Technology |
- Stock Market
- Insiders
- Karen Linehan
